GLP-2 T Tirzepatide 30mg
High-Dose Dual GIP/GLP-1 — Full Escalation Supply
Tirzepatide 30mg — covers the complete escalation from 2.5mg to 7.5mg/week in one vial. Optimal size for full SURMOUNT protocol dosing.
- Up to 22.5% body weight reduction — superior to semaglutide
- Dual GIP + GLP-1 agonism for complementary metabolic effects
- Covers first 12 weeks of SURMOUNT escalation protocol
- Outperformed semaglutide at all doses in SURPASS-2 trial
- Preferential visceral fat reduction
COA verified · US domestic shipping
Tirzepatide 30mg: Optimal Vial for Full-Protocol Dual GIP/GLP-1 Weight Loss
22.5% Weight Loss
SURMOUNT-1 at 15mg: 22.5% body weight reduction — the highest weight loss ever demonstrated in a controlled trial at that time.
Scalable Protocol
30mg covers the first 12 weeks of escalation — ideal first phase before moving to higher-dose vials.
Beat Semaglutide
SURPASS-2 direct comparison: tirzepatide outperformed semaglutide at 5mg, 10mg, and 15mg — at every dose tested.
Dual Mechanism
GIP + GLP-1 synergistic weight loss that neither receptor can achieve alone.
The Science Behind GLP-2 T Tirzepatide 30mg
Tirzepatide 30mg is the ideal vial for running a complete escalation protocol. SURMOUNT trial goes from 2.5mg/week to 15mg/week — a 30mg vial covers the first 3 escalation steps.
▸SURMOUNT-1 Results
At highest dose (15mg), tirzepatide produced 22.5% body weight reduction — significantly exceeding semaglutide's 15-16% in comparable populations.
Complete GLP-2 T Tirzepatide 30mg Benefits
- Up to 22.5% body weight reduction — superior to semaglutide
- Dual GIP + GLP-1 agonism for complementary metabolic effects
- Covers first 12 weeks of SURMOUNT escalation protocol
- Outperformed semaglutide at all doses in SURPASS-2 trial
- Preferential visceral fat reduction
GLP-2 T Tirzepatide 30mg Dosing Protocol
Escalation from 30mg Vial:
• Reconstitute with 3mL bacteriostatic water (10mg/mL)
• Weeks 1-4: 0.25mL (2.5mg) weekly
• Weeks 5-8: 0.5mL (5mg) weekly
• Weeks 9-12: 0.75mL (7.5mg) weekly — 22.5mg used
All information on this site is for educational purposes only. Always consult with a qualified healthcare provider before use. COA documentation is available from Apollo Peptide Sciences for all products.
Get GLP-2 T Tirzepatide 30mg
Apollo Peptide Sciences — COA verified, US domestic, fast shipping.
Shop View Stack ProtocolsGLP receptor agonists work via hypothalamic appetite regulation and metabolic enhancement — proven in large-scale clinical trials.
All Weight Loss PeptidesStacks Best With
Stack GLP-2 T Tirzepatide 30mg With
Anti-AgingNAD+ 500mg
Cellular Energy & Longevity Cofactor
NAD+ is the master cellular energy molecule that declines 50% by age 50 — supplementation restores sirtuin activity, DNA repair, and mitochondrial function.
Weight LossGLP-1 S (Semaglutide)
Next-Gen GLP-1 Receptor Agonist for Weight Loss
Semaglutide (GLP-1 S) is a GLP-1 receptor agonist with clinical trials showing 15-20% body weight reduction — the most effective pharmacological weight loss agent studied.
Weight LossGLP-2 T (Tirzepatide)
Dual GIP/GLP-1 Agonist — Superior Weight Loss
Tirzepatide (GLP-2 T) is a dual GIP/GLP-1 receptor agonist showing up to 22.5% body weight reduction in trials — outperforming semaglutide in head-to-head data.